score,metric,date,value,year,sentence,number
0.6147446036338806,marketable securities,"september 25, 2021 and",$17.9 billion,2021,"(3)as of september 25, 2021 and september 26, 2020, total marketable securities included $17.9 billion and $18.6 billion, respectively, that was restricted from general use, related to the state aid decision (refer to note 5, “income taxes”) and other agreements.",17900000000.0
0.4423773884773254,marketable securities,"september 26, 2020",$18.6 billion,2020,"(3)as of september 25, 2021 and september 26, 2020, total marketable securities included $17.9 billion and $18.6 billion, respectively, that was restricted from general use, related to the state aid decision (refer to note 5, “income taxes”) and other agreements.",18600000000.0
0.2071757763624191,r&d value,"september 25, 2021",$1.6 billion,2021,"as of september 25, 2021, the company had $2.6 billion in foreign tax credit carryforwards in ireland and $1.6 billion in california research and development credit carryforwards, both of which can be carried forward indefinitely",1600000000.0
0.1001256331801414,r&d value,2021,$3.5 billion,2021,"during 2021, the company established deferred tax assets (“dtas”) for foreign tax credit carryforwards in ireland and increased dtas for r&d tax credit carryforwards in california, which resulted in a combined $3.5 billion increase in the valuation allowance on the company’s dtas, with no effect on net income",3500000000.0
